Intraoperative optical identification of pituitary adenomas - PubMed (original) (raw)
Clinical Trial
Intraoperative optical identification of pituitary adenomas
M Sam Eljamel et al. J Neurooncol. 2009 May.
Abstract
Introduction: The main goals of transsphenoidal pituitary surgery are total removal of pituitary adenomas (PAs) and preservation of normal pituitary functions. Achieving these goals is dependent upon the precise localisation of PAs during surgery, particularly secreting microadenomas. However, some microadenomas are invisible on preoperative imaging and during surgery, leading some surgeons to perform total hypophysectomy in many patients to achieve cure at the expense of panhypopituitrism. We have examined optical detection systems to identify PAs intraoperatively. This paper reports our preliminary findings.
Methods: A prospective observational study design.
Technique: Patients were given 20 mg/kg body weight 5-aminolevulinic acid (ALA) mixed in 30 ml of orange juice, orally 3 h before surgery. Surgery was performed in the supine position, under image guidance, through the right nostril using Storz 0 degree endoscope assisted with microsurgery as required. The endoscope was attached to photodiagnostic filters (PD) allowing switching the light from white to blue at the flick of a foot pedal. After the dura of the floor of the sella was incised a laser probe was inserted into the pituitary gland to identify the ALA-induced protoporphyrin IX spectroscopy at 632 nm, using an optical biopsy system (OBS). Once the adenoma was identified by the OBS it was exposed and examined by the PD system to detect fluorescence. The PA was removed and its type was confirmed by histopathology and correlated to the OBS and PD system findings.
Patients: Thirty consecutive patients were studied: 14 were non-functioning macroadenomas (NFA), 12 were secreting PAs and 4 pituitary cysts. The secreting PAs were GH (2), ACTH (3), prolactin (2) and gonadotrophins (5). Six were microadenomas (3 ACTH, 1 GH, 2 prolactin) and 20 were macroadenomas, of which 12 were invading macroadenomas. Twenty-four of these were examined by the OBS and the PD systems and six were examined by the PD system only. The true positive (sensitivity) of the PD and OBS systems were 80.8% (21/26) and 95.5% (21/22) respectively. The true negative (specificity) of PD and OBS were 75% (3/4) and 100% (2/2) respectively. The false negative rate of PD was 19.2% (5/26) and for OBS was 4.5% (1/22), while the false positive rate for PD was 25% (1/4) and for OBS was 0.
Conclusion: Intraoperative optical identification of pituitary adenomas is a feasible and reliable way to localize pituitary adenomas during transsphenoidal surgery and it may lead to improved cure rate and preservation of normal pituitary functions.
Similar articles
- Endoscopic endonasal transsphenoidal surgery for functional pituitary adenomas.
Hofstetter CP, Shin BJ, Mubita L, Huang C, Anand VK, Boockvar JA, Schwartz TH. Hofstetter CP, et al. Neurosurg Focus. 2011 Apr;30(4):E10. doi: 10.3171/2011.1.FOCUS10317. Neurosurg Focus. 2011. PMID: 21456921 - The use of neuronavigation in transnasal transsphenoidal pituitary surgery.
Thomale UW, Stover JF, Unterberg AW. Thomale UW, et al. Zentralbl Neurochir. 2005 Aug;66(3):126-32; discussion 132. doi: 10.1055/s-2005-836602. Zentralbl Neurochir. 2005. PMID: 16116555 - Fluorescence-guided detection of pituitary neuroendocrine tumor (PitNET) tissue during endoscopic transsphenoidal surgery available agents, their potential, and technical aspects.
Vergeer RA, Theunissen REP, van Elk T, Schmidt I, Postma MR, Tamasi K, van Dijk JMC, Kuijlen JMA. Vergeer RA, et al. Rev Endocr Metab Disord. 2022 Jun;23(3):647-657. doi: 10.1007/s11154-022-09718-9. Epub 2022 Mar 28. Rev Endocr Metab Disord. 2022. PMID: 35344185 Free PMC article. Review. - Pathology of invasive pituitary tumors with special reference to functional classification.
Scheithauer BW, Kovacs KT, Laws ER Jr, Randall RV. Scheithauer BW, et al. J Neurosurg. 1986 Dec;65(6):733-44. doi: 10.3171/jns.1986.65.6.0733. J Neurosurg. 1986. PMID: 3095506 - Suprasellar pituitary adenomas: a 10-year experience in a single tertiary medical center and a literature review.
Zhu J, Wang Z, Zhang Y, Liu J, Li X, Deng K, Lu L, Yao Y. Zhu J, et al. Pituitary. 2020 Aug;23(4):367-380. doi: 10.1007/s11102-020-01043-1. Pituitary. 2020. PMID: 32378170 Review.
Cited by
- Fluorescence guidance in skull base surgery: Applications and limitations - A systematic review.
Suero Molina E, Bruneau M, Reuter G, Shahein M, Cavallo LM, Daniel RT, Kasper EM, Froelich S, Jouanneau E, Manet R, Messerer M, Mazzatenta D, Meling TR, Roche PH, Schroeder HW, Tatagiba M, Visocchi M, Prevedello DM, Stummer W, Cornelius JF; EANS Skull Base Section. Suero Molina E, et al. Brain Spine. 2024 Aug 29;4:103328. doi: 10.1016/j.bas.2024.103328. eCollection 2024. Brain Spine. 2024. PMID: 39309550 Free PMC article. Review. - Endoscopic endonasal pituitary surgery: How we do it. Consensus statement on behalf of the EANS skull base section.
Bove I, Solari D, Bruneau M, Berhouma M, Jouanneau E, Cornelius JF, Messerer M, Daniel RT, Froelich S, Mazzatenta D, Meling T, Paraskevopoulos D, Roche PH, Schoeder HWS, Zazpe I, Visocchi M, Kasper E, Tatagiba M, Cavallo LM. Bove I, et al. Brain Spine. 2023 Oct 8;3:102687. doi: 10.1016/j.bas.2023.102687. eCollection 2023. Brain Spine. 2023. PMID: 38021006 Free PMC article. - Current and Future Advances in Surgical Therapy for Pituitary Adenoma.
Khan DZ, Hanrahan JG, Baldeweg SE, Dorward NL, Stoyanov D, Marcus HJ. Khan DZ, et al. Endocr Rev. 2023 Sep 15;44(5):947-959. doi: 10.1210/endrev/bnad014. Endocr Rev. 2023. PMID: 37207359 Free PMC article. - The Party Wall: Redefining the Indications of Transcranial Approaches for Giant Pituitary Adenomas in Endoscopic Era.
Luzzi S, Giotta Lucifero A, Rabski J, Kadri PAS, Al-Mefty O. Luzzi S, et al. Cancers (Basel). 2023 Apr 10;15(8):2235. doi: 10.3390/cancers15082235. Cancers (Basel). 2023. PMID: 37190164 Free PMC article. Review. - 5-Aminolevulinic acid fluorescence-guided endoscopic surgery for intraventricular tumors.
Takeda J, Nonaka M, Li Y, Isozaki H, Kamei T, Hashiba T, Asai A. Takeda J, et al. Surg Neurol Int. 2022 Jul 15;13:302. doi: 10.25259/SNI_488_2022. eCollection 2022. Surg Neurol Int. 2022. PMID: 35928327 Free PMC article.
References
- J Clin Endocrinol Metab. 2005 Sep;90(9):5134-40 - PubMed
- Pituitary. 1999 Aug;2(2):117-22 - PubMed
- Lancet Oncol. 2006 May;7(5):392-401 - PubMed
- Acta Neurochir Suppl (Wien). 1991;53:72-6 - PubMed
- Neurol Neurochir Pol. 2004 May-Jun;38(3):201-7 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical